FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder - Yahoo Finance
Submitted by Anonymous (not verified) on Wed, 03/22/2023 - 12:30
